<p>Subgroup analysis of the association between VEGF -2578 C/A polymorphisms with response to chemotherapies in colorectal cancer (CC vs. CA).</p
Vascular endothelial growth factor (VEGF) is one of the most important regulators of angiogenesis. S...
a<p>: TNFAA+AG-VEGF GG+GC vs. TNFGG-VEGF GG+GC.</p>b<p>: TNFAA+AG-VEGF.GG+GC vs. TNFGG-VEGFCC.</p>c<...
<p>Subgroup analysis by cancer type of ORs for cancer risk associated with the <i>PARP-1 Val762Ala</...
<p>Subgroup analyses of the association between VEGF polymorphisms and response to chemotherapies in...
<p>(a) Analytical results of the genetic model of CC vs. CA in VEGF -2578 C/A polymorphism. (b) Resu...
<p>Meta-analysis of the association between VEGF polymorphisms and response to chemotherapies in CRC...
Some studies have investigated the effects of polymorphisms in the vascular endothelial growth facto...
Some studies have investigated the effects of polymorphisms in the vascular endothelial growth facto...
The vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen involved in th...
Aims: Colorectal cancer (CRC) is the third most common cancer in the world and its etiology involves...
<p>Subgroup analyses for association between VEGF-C expression and survival in BC patients.</p
The vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen involved in th...
Background and aims: Colorectal cancer (CRC) is the third most common cancer worldwide and is caused...
<p>Subgroup analysis by cancer type of ORs with a random-effects model for associations between surv...
BACKGROUND: Pharmacogenetic markers related to drug metabolism and mechanisms of action could help t...
Vascular endothelial growth factor (VEGF) is one of the most important regulators of angiogenesis. S...
a<p>: TNFAA+AG-VEGF GG+GC vs. TNFGG-VEGF GG+GC.</p>b<p>: TNFAA+AG-VEGF.GG+GC vs. TNFGG-VEGFCC.</p>c<...
<p>Subgroup analysis by cancer type of ORs for cancer risk associated with the <i>PARP-1 Val762Ala</...
<p>Subgroup analyses of the association between VEGF polymorphisms and response to chemotherapies in...
<p>(a) Analytical results of the genetic model of CC vs. CA in VEGF -2578 C/A polymorphism. (b) Resu...
<p>Meta-analysis of the association between VEGF polymorphisms and response to chemotherapies in CRC...
Some studies have investigated the effects of polymorphisms in the vascular endothelial growth facto...
Some studies have investigated the effects of polymorphisms in the vascular endothelial growth facto...
The vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen involved in th...
Aims: Colorectal cancer (CRC) is the third most common cancer in the world and its etiology involves...
<p>Subgroup analyses for association between VEGF-C expression and survival in BC patients.</p
The vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen involved in th...
Background and aims: Colorectal cancer (CRC) is the third most common cancer worldwide and is caused...
<p>Subgroup analysis by cancer type of ORs with a random-effects model for associations between surv...
BACKGROUND: Pharmacogenetic markers related to drug metabolism and mechanisms of action could help t...
Vascular endothelial growth factor (VEGF) is one of the most important regulators of angiogenesis. S...
a<p>: TNFAA+AG-VEGF GG+GC vs. TNFGG-VEGF GG+GC.</p>b<p>: TNFAA+AG-VEGF.GG+GC vs. TNFGG-VEGFCC.</p>c<...
<p>Subgroup analysis by cancer type of ORs for cancer risk associated with the <i>PARP-1 Val762Ala</...
DOI
Add to ORKG